Cited by 61Neuroendocrine regulation and behaviorStress Responses and CortisolNeuropeptides and Animal Physiology

Effects of a 10-day oxytocin trial in older adults on health and well-being

Barraza, Jorge A., Grewal, Naomi S., Ropacki, Susan, Perez, Pamela, Gonzalez, Anthony, Zak, Paul J.·2013·Experimental and Clinical Psychopharmacology

Abstract

The neuropeptide oxytocin (OT) modulates functioning of the hypothalamic-pituitary-adrenal (HPA) axis and regulates a range of social processes. Clinical studies have used intranasal OT administration to treat symptoms arising from a number of psychiatric disorders including autism, schizophrenia, and depression. Most of this research, however, has been based on single dose treatments of OT in younger adult populations. The present study examined the impact on the health and psychological well-being of a 10-day OT administration in an older adult population. Residentially housed older adults (N = 41, mean age of 80) were enrolled in a randomized, double-blind, placebo-controlled study. Participants received 40 IU intranasal OT or placebo for 10 consecutive days. No changes in mood or cardiovascular states were observed across the 10-day period. Repeated-measures ANOVAs showed that dispositional gratitude improved for the OT infused participants, although gratitude declined for placebo controls over the 10 days (p = .015). Those in the OT condition did not report a decline in physical functioning over time as was observed in the placebo condition (p = .05), and also reported less fatigue compared with controls (p = .03). No significant adverse events were reported throughout the entirety of the study, indicating that OT can be safely used with older adults.

Integrity signals

Registry

Crossref · 10.1037/a0031581

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Early studies of oxytocin in human aging suggest that higher oxytocin levels reduce age-related physical decline and fatigue.

    “on oxytocin administration in human aging provide first evidence that increased oxytocin levels ameliorate age-related physical decline and reduce fatigue (Barraza, Grewal, Ropacki, Perez, Gonzalez, and Zak 2013)”

    From Successful aging: Advancing the science of physical independence in older adults (2015) · cites this paper as Barraza, Grewal, Ropacki, Perez, Gonzalez, and Zak 2013

  • In humans, intranasal oxytocin treatment over 10 days in elderly subjects produced no significant effects on mood or cardiovascular indices but yielded positive changes in psychological well-being and physical functioning.

    “In humans, OXT IN treatment over 10 days in elderly subjects produced no significant effects on mood or the cardiovascular indices but yielded positive changes in psychological well-being and physical functioning (141).”

Cites

Flagged first, then by citations

1 of the 68 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Barraza, J. A., Grewal, N. S., Ropacki, S., Perez, P., Gonzalez, A., & Zak, P. J.
Affiliations
Claremont Graduate University (US)
Venue
Experimental and Clinical Psychopharmacology
Published
2013-04
Volume
21
Issue
2
Pages
85-92
ISSN
  • 1064-1297 (ISSN-L)
  • 1936-2293
OpenAlex
W2321799382
Cited by
61
References
68
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 6 · 2021: 2 · 2020: 6 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 5 · 2015: 8 · 2014: 4 · 2013: 4
FWCI
10.48
Type
journal article
Language
en
Open access
closed
Locations
  • Experimental and Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (1R21AG029871-01A2)
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
oxytocin, older adults, intranasal administration, dispositional gratitude, well-being, physical function, fatigue, hypothalamic-pituitary-adrenal axis, placebo effect, adverse events
MeSH terms
Aged, Aged, 80 and over, Analysis of Variance, Double-Blind Method, Humans, Middle Aged, Oxytocin, Placebos, Quality of Life

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review